-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508.P1.51 508. Bone Marrow Failure: Acquired: Poster I Clinically Relevant Abstract

Symposia: Bone Marrow Failure: Acquired Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Regis Peffault De Latour1,2*, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP3,4,5, Phillip Scheinberg, MD6, Philippe Ferber7*, Tomasz Lawniczek7*, Christine Thorburn8*, Marion Dahlke, MD, MSc9* and Antonio M Risitano, MD, PhD10,11

1French Référence Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France
2Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France
3King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, London, United Kingdom
4National Institute for Health and Care Research and Wellcome King’s Research Facility, London, United Kingdom
5King’s College London, London, United Kingdom
6Hospital A Beneficência Portuguesa, São Paulo, Brazil
7Novartis Pharma AG, Basel, Switzerland
8Novartis Pharmaceuticals UK Limited, London, United Kingdom
9Novartis, Basel, Switzerland
10AORN Moscati, Avellino, Italy
11University of Naples Federico II, Naples, Italy

Vincent Allain1,2*, Juliette Villemonteix1*, Thierry Leblanc3*, Florian Chevillon4*, Catherine Fortier1*, Mony Fahd3*, Jean-Hugues Dalle3*, Gerard Socié2,5,6, Regis Peffault De Latour5,6,7*, Sophie Caillat-Zucman1,2* and Flore Sicre De Fontbrune5,6*

1Laboratoire d'Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
2INSERM UMR 976, Université Paris Cité, Institut de Recherche Saint-Louis (IRSL), Paris, France
3Pediatric hematology and immunology department, Robert-Debré Hospital, GHU APHP Nord Université Paris-Cité, Paris, France
4Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris, France
5French National Reference Center for Aplastic Anemia, Paris, France
6Hematology and Transplant Unit, Saint Louis Hospital, APHP, Paris, France
7Université Paris Cité, Paris, France

Roma V. Rajput, MD1, Dalton Hironaka, BA1*, Ruba Shalhoub2*, Lemlem Alemu1*, Emma M. Groarke, MD3, Jennifer Lotter1*, Olga Rios1*, Ivana Darden, RN1*, Colin O. Wu, PhD2*, Fernanda Gutierrez-Rodrigues, PhD4, Xingmin Feng, PhD1*, Neal S. Young, MD1 and Bhavisha A. Patel, MD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
3Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
4Hematology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, Bethesda, MD

Andrew C. Hu, MS1,2*, Sushant Kumar, PhD2,3*, Aura Enache, BS2,4*, Brian M. Dulmovits, MD, PhD5*, Yash B. Shah, BS6,7*, Wenzhao Meng, PhD8*, Joseph H. Oved, MD3,9, Beatriz M. Carreno, PhD8,10*, Eline T. Luning Prak, MD, PhD8*, Timothy S Olson, MD, PhD3,7 and Daria V Babushok, MD, PhD2,3

1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
3Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA
4Drexel University College of Medicine, Philadelphia, PA
5Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA
6Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA
7Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
8Human Immunology Core and Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
9Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY
10Parker Institute for Cancer Immunotherapy and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA

Zuzana Lenertová, MSc1,2*, Monika Kaisrlikova, PhD3*, David Kundrat3*, Hana Votavova, PhD3*, Jitka Vesela3*, Iva Trsová3,4*, Sarka Ransdorfova3*, Iuri Marinov3*, Tomas Prochazka5*, Daniel Lysak5*, Anna Jonasova, MD, PhD6*, Jaroslav Čermák, MD, PhD3 and Monika Belickova, PhD3,7*

1Institute of Hematology and Blood Transfusion, Praha 2, Czech Republic
2First Faculty of Medicine, Charles University, Prague, Czech Republic
3Institute of Hematology and Blood Transfusion, Prague, Czech Republic
4Faculty of Science, Charles University, Prague, Czech Republic
5Department of Hematology and Oncology, Medical School and Teaching Hospital in Plzen, Charles University in Prague, Pilsen, Czech Republic
61st Medical Department, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
7First Faculty of Medicine, Institute of Clinical and Experimental Hematology, Charles University, Prague, Czech Republic

Yuemin Gong, M.D., PhD*, Xiaoyu Chen*, Yawen Zhang*, Guangsheng He, MD* and Jianyong Li, MD

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Dung Cao Cao Tran, MD1*, Yoshitaka Zaimoku, MD, PhD2, Kazuyoshi Hosomichi, PhD3*, Hiroki Mizumaki, MD, PhD4*, Kohei Hosokawa, MD, PhD5, Hirohito Yamazaki, MD, PhD6*, Toshihiro Miyamoto, MD, PhD5 and Shinji Nakao, MD, PhD5

1Department of Hematology, Kanazawa University, KANAZAWA, Japan
2Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan
3Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan
4Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Department of Hematology, Kanazawa University, Kanazawa, Ishikawa, Japan
6Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan

Wei Zhang1*, Li-xian Chang2,3*, Bei-bei Zhao2,3*, Dan-dan Shan1*, Bo-hao Tang1*, Fan Yang1*, Yue Zhou1*, Guo-xiang Hao1*, Yi Zheng1*, Ya-hui Zhang1,4*, John Van Den Anker5,6,7*, Xiaofan Zhu, MD2,3*, Li Zhang2,3* and Wei Zhao1,8*

1Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
3Tianjin Institutes of Health Science, Tianjin, China
4Department of Pharmacy,Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
5Departments of Pediatrics, Pharmacology & Physiology, Genomics & Precision Medicine, the George Washington University School of Medicine and Health Sciences, Washington, DC
6Division of Clinical Pharmacology, Children’s National Hospital, Washington, DC
7Department of Pediatric Pharmacology and Pharmacometrics, University of Basel Children’s Hospital, Basel, Switzerland
8NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, Qilu Hospital of Shandong University, Shandong University, Jinan, China

Caroline I Piatek, MD1, Jong-Wook Lee, MD2, Morag Griffin, FRCPath, MRCP3*, Jun-Ichi Nishimura, MD, PhD4, Christopher J. Patriquin5*, Hubert Schrezenmeier, MD6, Wilma Barcellini, MD7*, Jamile Shammo, MD8, Anna Gaya, MD9*, Yogesh Patel10*, Peng Liu10*, Karl-Johan Myrén10*, Flore Sicre De Fontbrune11*, Jens Panse, MD12 and Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP13

1University of Southern California / LAC+USC Medical Center, Los Angeles, CA
2Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Haematology, Leeds Teaching Hospitals, Leeds, GBR
4Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
5Division of Medical Oncology & Hematology, University Health Network, Toronto, Canada
6Institute of Transfusion Medicine, University of Ulm, Ulm, Germany and Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, University Hospital of Ulm and German Red Cross Blood Service Baden-Württemberg-Hessen, Ulm, Germany
7Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
8Feinberg School of Medicine, Northwestern University, Chicago, IL
9Hospital Clínic de Barcelona, Barcelona, Spain
10Alexion, AstraZeneca Rare Disease, Boston, MA
11Centre de Référence Aplasie Médullaire, Service d'Hématologie Greffe, Assistance Publique des Hôpitaux de Paris, Hôpital Saint-Louis, PARIS, FRA
12Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen and Center for Integrated Oncology, Aachen Bonne Cologne Düsseldorf (ABCD), Aachen, Germany
13King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, London, United Kingdom

Flore Sicre De Fontbrune1*, Mony Fahd2*, Édouard Forcade3*, Suzanne Tavitian4*, Cécile Moluçon Chabrot5*, Fiorenza Barraco6*, Yosr Hicheri7*, Delphine Lebon8*, Sébastien Maury9*, Anne-Lise Menard10*, Barbara Możejko-Pastewka11*, Kevin D Wolter12*, Bruno Valtier13*, Thierry Leblanc14* and Regis Peffault De Latour15*

1Service Hematologie Greffe, Centre de Reference des Aplasies Medullaires Acquises et Constitutionnelles, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France
2Service d’Hématologie et d’Immunologie Pédiatrique, Centre de Reference Aplasies Medullaires Acquises et Constitutionnelles, Hôpital Robert-Debré, Assistance Publique Hôpitaux de Paris, Paris, France
3Department of Hematology, Bordeaux University Hospital, Bordeaux, France
4Service d’Hematologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre hospitalier universitaire de Toulouse, Toulouse, France
5CHU de Clermont Ferrand, Clermont Ferrand, France
6Service d’Hematologie Clinique, Hôpital universitaire, Lyon, France
7Department of Hematology, Institut Paoli-Calmettes, Marseille, France
8Service d'hématologie clinique et thérapie cellulaire, université de Picardie-Jules-Verne, CHU d'Amiens Site Sud, Amiens, France
9Service d’Hématologie, Hôpital Henri Mondor, Créteil, France
10Centre Henri-Becquerel, département d'hématologie clinique, Rouen, France
11Pfizer, Warsaw, Poland
12Pfizer, New York, NY
13Pfizer, Paris, France
14Service d’Hematologie et d’Immunologie Pédiatrique, Centre de Reference Aplasies Medullaires Acquises et Constitutionnelles, Hôpital Robert-Debré, Assistance Publique Hôpitaux de Paris and Université Paris Cité, Paris, France
15Service Hematologie Greffe, Centre de Reference Aplasies Medullaires Acquises et Constitutionnelles, Universite Paris Diderot, Sorbonne Paris Cite, Hopital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris, France

Wenrui Yang*, Xin Zhao, Guangxin Peng*, Huihui Fan*, Kang Zhou*, Lei Ye, MD*, Jianping Li*, Yuan Li*, Liping Jing, MD*, Li Zhang* and Fengkui Zhang*

Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China

Ashvind Prabahran, MBBS, FRACP, FRCPA1,2,3,4*, Ash Lee Manley4*, Zhijie Wu, MD PhD4*, Shouguo Gao, PhD4*, Hiroki Mizumaki, MD PhD4*, Christian Combs, PhD5*, Jichun Chen, PhD4, Xingmin Feng, PhD4* and Neal S. Young, MD4

1Department of Clinical Haematology and Bone Marrow Transplantation, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
2Department of Medicine, The University of Melbourne, Parkville, VIC, Australia
3ACRF Laboratory, The Royal Melbourne Hospital, Parkville, VIC, Australia
4Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Menglu Zhang, MD1*, Xuan Wang2*, Chen Yang3*, Miao Chen4*, Junling Zhuang, MD, PhD1 and Bing Han, MD, PhD5*

1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
2Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
3Peking Union Medical College Hospital, Beijing, China
4Peking Union Medical College Hospital,Chinese Academy of Medical Sciences, Beijing, China
5Dept. of Hematology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College, Beijing, China

Lei Ye, MD1*, Xin Zhao1, Liping Jing, MD2*, Guangxin Peng1*, Fengkui Zhang3* and Li Zhang1*

1Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
2Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, AL, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Anemia Therapeutic Center, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Zehra Tombul1*, Waled Bahaj, MD2, Merve Ozturk1*, Bhavisha A. Patel, MD3, Alina Dulau-Florea, MD4*, Ahmet Celal Toprak, B.S.5*, Ibrahim F. Ibrahim, M.D.6, Weina Chen7*, Franklin Fuda8*, Olisaemeka Ogbue9, Carmelo Gurnari, MD10,11, Charles Parker12*, Neal S. Young, MD3, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP10, Munevver Duran, BA1* and Taha Bat, MD13

1UT Southwestern Medical Center, Dallas, TX
2Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
3Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
4Hematology Service, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
5University of Texas Southwestern Medical Center, Dallas, TX
6Department of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX
7Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX
8Department of Pathology, UT Southwestern Medical Center, Dallas, TX
9Cleveland Clinic Foundation, Rocky River, OH
10Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
11Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
12Division of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, UT
13Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX

Xiaoqing Liu1*, Xiaoyu Chen2*, Yuemin Gong, M.D., PhD2*, Qiqiang Long3*, Guangsheng He, MD4* and Jianyong Li, MD2

1Hematology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China
2Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
3The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China
4The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Yoshitaka Zaimoku, MD, PhD1,2, Tatsuya Imi, MD, PhD1*, Tatsuya Hatada, MD1*, Hiroki Mura, MD1*, Hiroki Yoshino, MD1*, Dung Cao Cao Tran, MD1*, Yasuhito Nannya, MD, PhD3, Seishi Ogawa4, Kazuyoshi Hosomichi, PhD5*, Noriko Doki, MD, PhD6, Yuta Katayama, MD, PhD7, Takashi Koike, MD8*, Ken-ichi Matsuoka, MD, PhD9*, Tetsuya Nishida, MD, PhD10*, Yoshiyuki Takahashi, MD, PhD11, Keisuke Kataoka, MD, PhD12*, Hideyuki Nakazawa, MD, PhD13*, Yasunori Ueda, MD, PhD14, Takahiro Fukuda, MD, PhD15*, Tatsuo Ichinohe, MD, PhD16, Fumihiko Ishimaru, MD, PhD17, Makoto Onizuka, MD, PhD18, Yoshiko Atsuta, MD, PhD19,20* and Toshihiro Miyamoto, MD, PhD1

1Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan
2Department of Infection Control and Prevention, Kanazawa University Hospital, Kanazawa, Japan
3Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Sakyoku, KYO, Japan
5Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, JPN
6Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
7Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
8Department of Pediatrics, Tokai University School of Medicine, Isehara, JPN
9Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
10Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
11Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
12Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
13Department of Hematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan
14Department of Hematology/Oncology, Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Japan
15Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
16Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
17Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan
18Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
19Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
20Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan

*signifies non-member of ASH